BUB1B and neoplasm: Another study proved that knockdown of BUB1B resulted in inhibition of tumor growth in vivo, including the regression of established tumors via postmitotic endoreduplication checkpoint [20] which is the replication of the genome during the cell cycle without the subsequent completion of mitosis and/or cytokinesis [21].